News

JPMorgan Downgrades Bank Mandiri Stock Amid Liquidity Concerns

JPMorgan Downgrades Bank Mandiri Stock Amid Liquidity Concerns

JPMorgan Downgrades Bank Mandiri Stock

In a recent move, JPMorgan has downgraded Bank Mandiri (BMRI:IJ) from an Overweight to a Neutral rating. This shift is attributed to tightening liquidity conditions in the Indonesian market, prompting JPMorgan to revise its price target for the stock to IDR7,500.00, down from IDR8,000.00. This adjustment reflects the bank's cautious outlook regarding its future growth under current economic pressures.

Reasons for Downgrade

The downgrade is backed by several influential factors affecting the financial landscape. Analysts highlight the recent increase in US/ID 10-year yields, which have spiked by 58 and 31 basis points respectively since the lows observed in September. Additionally, yields from Bank Indonesia’s SRBI have risen by 20 basis points, while the Indonesian Rupiah has depreciated by 3.6%.

Moreover, the growth of money supply has slowed to 7.3% in August, raising concerns about the potential impact on deposit and loan growth for Bank Mandiri. There's indication that the growth trajectory of current accounts and savings accounts (CASA) within the bank may also experience a slowdown, as growth rates have diminished to 13.8% in August, down from an average of 16.1% from May to July.

Long-Term Outlook

Despite these short-term challenges highlighted by JPMorgan, the bank maintains an optimistic medium to long-term outlook for Bank Mandiri. The firm has recalibrated its growth forecasts for loans and deposits in 2024 in light of tightening liquidity conditions. Notably, JPMorgan still anticipates a robust loan growth rate of approximately 15% for 2025 and 2026, signaling confidence in the bank's resilience.

In terms of earnings, JPMorgan’s estimate for earnings per share (EPS) for 2024 is positioned at 3% below market consensus. However, their forecasts for 2025 and 2026 suggest a more favorable trend, projecting that EPS could exceed the average estimates by 4% and 10%, respectively.

Bank Mandiri’s Financial Performance

Exploring further insights into Bank Mandiri’s performance, the bank's current market capitalization stands impressively at $40.46 billion, illustrating its dominant role in the Indonesian banking sector. This valuation reinforces the perspective of Bank Mandiri as a significant player in the banking industry.

Even in the wake of JPMorgan's downgrade, the bank’s financial health remains solid with a price-to-earnings (P/E) ratio of 11.3, which is relatively attractive given the bank's earnings growth potential. It appears that Bank Mandiri is trading at a low P/E ratio compared to its near-term earnings growth, which may appeal to value-oriented investors.

Profitability Metrics

The bank has not only demonstrated stability but has also shown consistent profitability, marked by an operating income margin of 58.42% over the past twelve months as of Q2 2024. This strong profitability is a positive indicator for shareholders, showing that the bank remains efficient in managing its resources and generating income.

Frequently Asked Questions

What led to JPMorgan's downgrade of Bank Mandiri?

The downgrade was primarily due to tightening liquidity conditions in Indonesia, impacting the bank's growth projections.

What is Bank Mandiri’s new price target set by JPMorgan?

JPMorgan has set the new price target for Bank Mandiri at IDR7,500.00, down from IDR8,000.00.

How has Bank Mandiri's profitability been in recent months?

Bank Mandiri has shown consistent profitability, with a notable operating income margin of 58.42% in the last twelve months.

What are the long-term growth projections for Bank Mandiri?

JPMorgan anticipates approximately 15% loan growth for the years 2025 and 2026, indicating a positive outlook.

Is the current P/E ratio of Bank Mandiri considered low?

Yes, Bank Mandiri has a P/E ratio of 11.3, which is relatively low compared to its earnings growth potential, making it attractive for investors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bybit Expands ByPick Game with Broader Market Reach

Updated Category News Views 117

Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...

Continue Reading
Estonian Apartments Fortify Foundations with Penetron

Updated Category News Views 57

Cementing Long-Term Trust in Tartu Apartments When you're talking about real estate, especially with high groundwater levels, a solid foundation isn't just a metaphor—it's a lifeline. The 18-unit Saekoja 5 project in Tartu, Estonia, recognized this from the get-go, deciding to put PENETRON ADMIX SB through its paces for the elevator pits and foundation slab. Near the...

Continue Reading
PSE&G Gains Top Spot in JD Power Rankings: What's Behind the Success?

Updated Category News Views 86

PSE&G Climbs To Number One Spot: What's Changed? Public Service Electric & Gas (PSE&G), New Jersey's largest utility, just snagged the top spot for business electric customer satisfaction in the East, according to JD Power's latest study. This is an upgrade from their second place showing in 2025. But how did they leapfrog their competition to reach the pinnacle? The...

Continue Reading
Endava Faces Class Action: Investor Reactions and Next Steps

Updated Category News Views 87

Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....

Continue Reading
TCL Electronics Surges with 54.5% Profit Increase in 2026

Updated Category News Views 68

TCL Electronics: Riding High on Strategic Moves Buckle up, because TCL Electronics has popped the hood and revealed quite the engine for growth. In the first three quarters of 2026, they cranked their adjusted profit up by a whopping 54.5%, hitting HK$2.24 billion. It's a hefty lift that would make any investor sit up and take notice. What's pushing this upswing? A...

Continue Reading
Longsys and Lexar Push Boundaries in Edge AI Storage

Updated Category News Views 160

Longsys and Lexar: A Revolution in Storage Ah, the tech world—it's like a fast-moving express train you just can't afford to miss. Longsys and its sidekick Lexar are in the spotlight this time, and boy, they've got some head-turning announcements. At electronica 2026 in Munich, they're playing the storage game hard. From industrial-grade mSSD to automotive solutions,...

Continue Reading
Worker.ai Acquires DeltaGen to Spice Up SMB Growth

Updated Category News Views 130

Betting Big on Small Business If you've ever run a small business, you know it can feel like a hamster wheel—more customers usually mean more headaches. But here comes Worker.ai, stepping onto the scene with big promises and a fancy new acquisition. They've scooped up DeltaGen—a mover in real-time AI tech—and launched a platform to hand these overworked owners a...

Continue Reading
New Senior Care Location Opens in Broward County

Updated Category News Views 174

A Personal Mission Driving Business in Hollywood Dive deep into any community, and you'll often find stories that tug at the heartstrings—especially when they're about family. That's the case with Saudia Sital, a Broward County local who's just opened Always Best Care Senior Services in Hollywood, Florida. Her journey from personal caregiver to business owner isn't just...

Continue Reading
Holographics Revolutionize Home Security Innovation

Updated Category News Views 65

Holographics in Home Security: A Game Changer? Pittsburgh isn't exactly the Silicon Valley, but it seems like InventHelp's latest brainchild, the HOLOSECURE HUB, may bring a slice of futuristic tech to our living rooms. Crafted by a forward-thinking mind out of Indianapolis, this gizmo promises to blend the flashy, sci-fi allure of holographics with practical AI-driven...

Continue Reading
CSTS Backs Hong Kong's Nobel Sustainability Trust Put

Updated Category News Views 133

A New Chapter for CSTS and Sustainability Leadership Who would've thunk it? CSTS Enterprises, primarily known for its integrated media and sports ventures, is stepping into the sustainability arena as the Official Hospitality Partner for the Nobel Sustainability Trust Hong Kong Summit 2026. They're not just dipping a toe—they're diving headfirst into the pool, bringing...

Continue Reading

Top 5 Most Recently Viewed Articles

IMF Delegates Argentina Negotiations Amid Rising Tensions

Updated Category News Views 196

Understanding the Recent Developments in IMF Talks with Argentina The International Monetary Fund (IMF) is currently navigating a complicated landscape in its negotiations with Argentina, showcasing the ever-evolving nature of international finance and politics. Recently, Rodrigo Valdes, the IMF director for the Western Hemisphere, has officially assigned all negotiation...

Continue Reading
IO Biotech Showcases Innovative Cancer Treatments Through Vaccines

Updated Category News Views 194

IO Biotech Unveils Breakthrough Pre-Clinical Data for Cancer Vaccines IO Biotech, a clinical-stage biopharmaceutical company listed on the Nasdaq under the ticker IOBT, is at the forefront of developing immune-modulatory, off-the-shelf therapeutic cancer vaccines. Recently, the company revealed exciting data highlighting its two promising candidates: IO112 and IO170, both...

Continue Reading
Market Performance of Marijuana Stocks This October

Updated Category News Views 69

October Marijuana Stock Performance Overview The marijuana stock market has shown a diverse range of movements this October. Investors and enthusiasts remain eager to analyze these trends as companies navigate the ever-changing landscape of the cannabis industry. This article provides insights into the key movers within this sector, identifying both the top performers and...

Continue Reading
EQS Group Unveils 'Q': AI-Driven Compliance Revolution

Updated Category News Views 216

Compliance in the Fast Lane The compliance world just got a hefty upgrade with EQS Group's latest rollout: 'Q by EQS,' an AI-powered intelligence layer that's here to shake up the way compliance tasks are handled. It's integrated right into the heart of the EQS Compliance Cockpit, giving teams an edge by automating those pesky, time-sucking routines and guiding them...

Continue Reading
Olema Oncology Showcases Innovations at J.P. Morgan Healthcare Expo

Updated Category News Views 306

Olema Oncology to Present at Major Healthcare Event Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a dynamic clinical-stage biopharmaceutical company focused on developing targeted therapies for breast cancer and related conditions, is all set to present its innovative findings at the renowned J.P. Morgan Healthcare Conference. This key...

Continue Reading